Click here to close now.

Welcome!

News Feed Item

Elite Traders Group Offers Insights on Biotech Industry Comparing It to the Next Computer Age

The Following Is an Investment Opinion Being Issued by the Elite Traders Group LLC

NEW YORK, NY -- (Marketwire) -- 01/14/13 -- Insights on the Following Companies: International Stem Cell Corporation, Kraig Biocraft Laboratories, Inc. ScripsAmerica, Inc., Celsion Corp.

Biotech researchers across the world are experiencing a renaissance in their industry. Like the massive growth experienced by technology companies of the 90s, the biotech industry is prepped and ready to realize the same growth. Technology has provided new ways to research treatments, therapies and distribute new drugs. Many small biotech companies have taken advantage of this new technology and are the source of these new drugs. With many patents expiring in 2012, the large corporations are beginning to acquire these smaller companies in an effort to attain new patents.

With new discoveries every day in the biotech industry the shelf life of a new drug is becoming shorter. According to information gathered by Bloomberg, 676 biotech takeovers occurred in rising numbers over the last 3 years. Expect this trend to continue over the next 3 years, as more patents will expire and new drugs will be discovered at an increasingly higher rate.

Researchers have just started to scratch the surface in this young and exciting field. 2012 revealed many advances in the Anti-obesity, Myelofibrosis, cancer, HCV, RA, MS, psoriasis, HCC, and dyslipidemia fields. 2013 promises to discover new treatments for viruses, targeted cancer treatments, Alzheimer's, antivirals and orphan diseases. In addition, many oral therapies are being researched in the areas of RA, Psoriasis, and MS. Stem cell research will also be represented well in 2013.

Investors continue to be unafraid of the lengthy and difficult process to achieve FDA approval. In fact, many have plans to increase the M&A budgets. Many small biotech companies are also seeing the oncoming wave of advancements in this field and have decided to take on the challenge of doing their own marketing. The rewards well outweigh the risks for these small biotech companies.

The biotech industry has many up and coming companies that are worth taking a closer look.

International Stem Cell Corporation (OTCQB: ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). http://www.firstpennypicks.com/get-your-free-research-report/

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development of high performance polymers. Kraig works in cooperation with leading universities in the fields of genetics and genetic engineering to develop new recombinant fibers and materials which the company believes will have broad commercial applications. http://www.firstpennypicks.com/get-your-free-research-report/

ScripsAmerica, Inc. (OTCQB: SCRC) delivers pharmaceutical products to a wide range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies through the largest pharmaceutical distributor in North America, McKesson Corporation. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration. http://www.firstpennypicks.com/get-your-free-research-report/

Celsion Corp. (NASDAQ: CLSN) is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, the Kyungpook National University Hospital and the Beijing Cancer Hospital. http://www.firstpennypicks.com/get-your-free-research-report/

To Receive More Reports like this one Subscribe free at http://www.FirstPennyPicks.com

VIP Group

Increase Your Day Trading Profits by joining our VIP Pre-promotion/Early Alert Membership For only $29.95/month or $295/year: http://www.firstpennypicks.com/vip-membership/

http://www.Firstpennypicks.com was developed as a beacon of hope in the micro-cap stock newsletter industry. We always hand-pick our alerts as opposed to biased advertising. This is why we are the fastest growing community of micro-cap traders on the web.

Please note that all media from Elite Traders Group LLC and FirstPennyPicks.com is investment opinion only. Elite Traders Group employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This advertisement is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the profiled companies listed here.

FULL DISCLAIMER http://www.firstpennypicks.com/disclaimer/

Contact:
Elite Traders Group LLC
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
"We have a tagline - "Power in the API Economy." What that means is everything that is built in applications and connected applications is done through APIs," explained Roberto Medrano, Executive Vice President at Akana, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and Containers together help companies to achieve their business goals faster and more effectively. In his session at DevOps Summit, Ruslan Synytsky, CEO and Co-founder of Jelastic, reviewed the current landscape of...
"AgilData is the next generation of dbShards. It just adds a whole bunch more functionality to improve the developer experience," noted Dan Lynn, CEO of AgilData, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists addressed this very serious issue of pro...
The cloud has transformed how we think about software quality. Instead of preventing failures, we must focus on automatic recovery from failure. In other words, resilience trumps traditional quality measures. Continuous delivery models further squeeze traditional notions of quality. Remember the venerable project management Iron Triangle? Among time, scope, and cost, you can only fix two or quality will suffer. Only in today's DevOps world, continuous testing, integration, and deployment upend...
"We provide a web application framework for building really sophisticated web applications that run on a browser without any installation need so we get used for biotech, defense, and banking applications," noted Charles Kendrick, CTO and Chief Architect at Isomorphic Software, in this SYS-CON.tv interview at @DevOpsSummit (http://DevOpsSummit.SYS-CON.com), held June 9-11, 2015, at the Javits Center in New York
Discussions about cloud computing are evolving into discussions about enterprise IT in general. As enterprises increasingly migrate toward their own unique clouds, new issues such as the use of containers and microservices emerge to keep things interesting. In this Power Panel at 16th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the state of cloud computing today, and what enterprise IT professionals need to know about how the latest topics and trends affect t...
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an Internet of Things implementation? In his session at @ThingsExpo, James Kirkland, Red Hat's Chief Arch...
In the midst of the widespread popularity and adoption of cloud computing, it seems like everything is being offered “as a Service” these days: Infrastructure? Check. Platform? You bet. Software? Absolutely. Toaster? It’s only a matter of time. With service providers positioning vastly differing offerings under a generic “cloud” umbrella, it’s all too easy to get confused about what’s actually being offered. In his session at 16th Cloud Expo, Kevin Hazard, Director of Digital Content for SoftL...
"A lot of the enterprises that have been using our systems for many years are reaching out to the cloud - the public cloud, the private cloud and hybrid," stated Reuven Harrison, CTO and Co-Founder of Tufin, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.
The time is ripe for high speed resilient software defined storage solutions with unlimited scalability. ISS has been working with the leading open source projects and developed a commercial high performance solution that is able to grow forever without performance limitations. In his session at Cloud Expo, Alex Gorbachev, President of Intelligent Systems Services Inc., shared foundation principles of Ceph architecture, as well as the design to deliver this storage to traditional SAN storage co...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society-changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his session at @ThingsExpo, Jason Mondanaro, Director, Product Management at Metanga, discussed how you can plan to cooperate, partner, and form lasting all-star teams to change the world...